| ||||||||||||||
|
|
|||||||||||||

From the *Department of Anesthesia, University of Toronto, and the
Department of Anesthesia, University Health Network, University of Toronto, Toronto, ON
Address correspondence and reprint requests to Dr. W. Scott Beattie, MD, PhD, Associate Professor, Department of Anesthesia, University of Toronto, EN 3453, Toronto General Hospital, 200 Elizabeth Street, Toronto, ON, M5G 2C4, Canada. Address email to scott.beattie{at}uhn.on.ca
Cardiac complications are the leading cause of death after noncardiac surgery. Despite theoretical benefits, calcium channel blockers (CCB) are not widely used in the perioperative setting. This systematic review assessed the efficacy of CCBs during noncardiac surgery. MEDLINE, EMBASE, Science Citation Index, PubMed, and reference lists were searched without language restriction for randomized controlled trials (RCT) evaluating CCBs during noncardiac surgery. Two reviewers independently abstracted data on death, myocardial infarction (MI), ischemia, supraventricular tachyarrhythmia (SVT), and congestive heart failure (CHF). Treatment effects were calculated as relative risks (RR) with 95% confidence intervals (CI). Eleven studies (1007 patients) were included. CCBs significantly reduced ischemia (RR, 0.49; 95% CI, 0.300.80; P = 0.004) and SVT (RR, 0.52; 95% CI, 0.370.72; P < 0.0001). CCBs were associated with trends towards reduced death and MI. In post hoc analyses, CCBs significantly reduced death/MI (RR, 0.35; 95% CI, 0.150.86; P = 0.02) and major morbid events (MME), defined as death, MI, or CHF (RR, 0.39; 95% CI, 0.170.89; P = 0.02). In subgroup analyses, diltiazem significantly reduced ischemia, SVT, death/MI, and MMEs. This meta-analysis shows CCBs significantly reduced ischemia, SVT, and combined end-points in the setting of noncardiac surgery. The majority of these benefits are attributable to diltiazem, suggesting the need for further evaluation of this drug in a large RCT.
IMPLICATIONS: This meta-analysis evaluated the efficacy of calcium channel-blockers (CCB) for preventing cardiac complications after noncardiac surgery. Eleven relevant randomized controlled trials were identified. Overall, CCBs reduced major cardiac morbid events, with most benefits being attributable to diltiazem.
This article has been cited by other articles:
![]() |
G. Landesberg, W. S. Beattie, M. Mosseri, A. S. Jaffe, and J. S. Alpert Perioperative Myocardial Infarction Circulation, June 9, 2009; 119(22): 2936 - 2944. [Full Text] [PDF] |
||||
![]() |
M. D. Kertai, C. M. Westerhout, K. S. Varga, G. Acsady, and J. Gal Dihydropiridine calcium-channel blockers and perioperative mortality in aortic aneurysm surgery Br. J. Anaesth., October 1, 2008; 101(4): 458 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Biccard and S. J. Howell Calcium channel blockers, beta-blockers, and perioperative cardiovascular stability Br. J. Anaesth., October 1, 2008; 101(4): 439 - 441. [Full Text] [PDF] |
||||
![]() |
W. S. Beattie, D. N. Wijeysundera, K. Karkouti, S. McCluskey, and G. Tait Does Tight Heart Rate Control Improve Beta-Blocker Efficacy? An Updated Analysis of the Noncardiac Surgical Randomized Trials Anesth. Analg., April 1, 2008; 106(4): 1039 - 1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
Developed in Collaboration With the American Socie, WRITING COMMITTEE MEMBERS, L. A. Fleisher, J. A. Beckman, K. A. Brown, H. Calkins, E. Chaikof, K. E. Fleischmann, W. K. Freeman, J. B. Froehlich, et al. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) Anesth. Analg., March 1, 2008; 106(3): 685 - 712. [Full Text] [PDF] |
||||
![]() |
L. A. Fleisher, J. A. Beckman, K. A. Brown, H. Calkins, E. Chaikof, K. E. Fleischmann, W. K. Freeman, J. B. Froehlich, E. K. Kasper, J. R. Kersten, et al. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery J. Am. Coll. Cardiol., October 23, 2007; 50(17): 1707 - 1732. [Full Text] [PDF] |
||||
![]() |
L. A. Fleisher, J. A. Beckman, K. A. Brown, H. Calkins, E. L. Chaikof, K. E. Fleischmann, W. K. Freeman, J. B. Froehlich, E. K. Kasper, J. R. Kersten, et al. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery J. Am. Coll. Cardiol., October 23, 2007; 50(17): e159 - e242. [Full Text] [PDF] |
||||
![]() |
L. A. Fleisher, J. A. Beckman, K. A. Brown, H. Calkins, E. L. Chaikof, K. E. Fleischmann, W. K. Freeman, J. B. Froehlich, E. K. Kasper, J. R. Kersten, et al. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) Circulation, October 23, 2007; 116(17): e418 - e500. [Full Text] [PDF] |
||||
![]() |
L. A. Fleisher, J. A. Beckman, K. A. Brown, H. Calkins, E. L. Chaikof, K. E. Fleischmann, W. K. Freeman, J. B. Froehlich, E. K. Kasper, J. R. Kersten, et al. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) Circulation, October 23, 2007; 116(17): 1971 - 1996. [Full Text] [PDF] |
||||
![]() |
M. Licker, J. Diaper, and C. Ellenberger Perioperative {beta}-Blockade: Still Not Enough for Adequate Cardioprotection! Anesth. Analg., July 1, 2007; 105(1): 278 - 279. [Full Text] [PDF] |
||||
![]() |
O. Schouten, J. J Bax, and D. Poldermans Assessment of cardiac risk before non-cardiac general surgery Heart, December 1, 2006; 92(12): 1866 - 1872. [Full Text] [PDF] |
||||
![]() |
W. S. Beattie, E. Abdelnaem, D. N. Wijeysundera, and D. N. Buckley A Meta-Analytic Comparison of Preoperative Stress Echocardiography and Nuclear Scintigraphy Imaging Anesth. Analg., January 1, 2006; 102(1): 8 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.J. Devereaux, L. Goldman, S. Yusuf, K. Gilbert, K. Leslie, and G. H. Guyatt Surveillance and prevention of major perioperative ischemic cardiac events in patients undergoing noncardiac surgery: a review Can. Med. Assoc. J., September 27, 2005; 173(7): 779 - 788. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Comfere, J. Sprung, M. M. Kumar, M. Draper, D. P. Wilson, B. A. Williams, D. R. Danielson, L. Liedl, and D. O. Warner Angiotensin System Inhibitors in a General Surgical Population Anesth. Analg., March 1, 2005; 100(3): 636 - 644. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tabel, H. Hepaguslar, C. Erdal, H. Catalyurek, U. Acikel, Z. Elar, and O. Aslan Diltiazem provides higher internal mammary artery flow than nitroglycerin during coronary artery bypass grafting surgery Eur. J. Cardiothorac. Surg., April 1, 2004; 25(4): 553 - 559. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Butterworth and C. D. Furberg Improving Cardiac Outcomes After Noncardiac Surgery Anesth. Analg., September 1, 2003; 97(3): 613 - 615. [Full Text] [PDF] |
||||
|